RELATED REFERENCES

  1. Harmatz P., Mengel K.E., Giugliani R., et al. The Morquio A Clinical Assessment Program: Baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Mol Genet Metab (2013) 109;1:54–61.
  2. Solanki G.A., Lo W.B., Hendriksz C.J. MRI morphometric characterisation of paediatric cervical spine and spinal cord in children with MPS IVA (Morquio-Brailsford syndrome). J Inherit Metab Dis. (2013) 36;2:329–37.
  3. Montano A.M., Tomatsu S., Gottesman G.S., Smith M., Orii T. International Morquio A Registry: Clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis (2007) 30:165–174.
  4. White K.K., Harmatz P. Orthopedic management of mucopolysaccharide disease. J Pediatr Rehabil Med. (2010) 3;1:47–56.
  5. Walker R., Belani K.G., Braunlin E.A., et al. Anaesthesia and airway management in mucopolysaccharidosis. J Inherit Metab Dis. 2013 36;2:211.9.
  6. Swiedler S.J., Beck M., Bajbouf M., et al. Threshold Effect of Urinary Glycosaminoglycans and the Walk Test as Indicators of Disease Progression in a Survey of Subjects With Mucopolysaccharidosis VI (Marateaux-Lamy Syndrome). American Journal of Medical Genetics (2005) 134A:144–150.
  7. Arn P., Whitley C., Wraith J.E., Warner Webb H., Underhill L., Rangachari L., Cox G.F. High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry. Journal of Pediatric Surgery (2012) 47:477–484.
  8. Mendelsohn N.J., Wood T., Olson R.A., Temee R., Hale S. Zhang H., Read L. White K.K. Spondyloepiphyseal Dysplasias and Bilateral Legg-Calvé-Perthes Disease: Diagnostic Considerations for Mucopolysaccharidoses. JIMD Rep. (2013) 11:125–32.
  9. Pelley C.J., Kwo J., Hess D.R. Tracheomalacia in an adult with respiratory failure and Morquio syndrome. Respir Care (2007) 52:278–282.
  10. Walker P.P., Rose E., Williams J.G. Upper airways abnormalities and tracheal problems in Morquio’s disease. Thorax (2003) 58:458–459.
  11. Braunlin E.A., Harmartz P.R., Scarpa M., et al. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis. 2011 34;6:1183–97.
  12. Neufeld E.F., Muenzer J.: The Mucopolysaccharidoses. In The Metabolic and Molecular Bases of Inherited Disease Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill; (2001) 3421–3452.
  13. Northover H., Cowie R.A., Wraith J.E. Mucopolysaccharidosis type IVA (Morquio syndrome): A clinical review. J Inherit Metab Dis. (1996) 19:357–365.
  14. Berger K.I., Fagondes S.C, Giugliani R., et al. Respiratory and sleep disorders in mucopolysaccharidosis. J Inherit Metab Dis. (2013) 36;2:201–10.
  15. Valayannopoulos V., Nicely H., Harmatz P., Turbeville S. Mucopolysaccharidosis VI. Orphanet Journal of Rare Diseases. (2010) 5:5.
  16. Hendriksz C.J., Al–Jawad M., Berger K.I., et al. Clinical overview and treatment options for non-skeletal manifestations of
    mucopolysaccharidosis type IVA. J Inherit Metab Dis. (2013) 36;2:309–22.
THE CONTENT AVAILABLE THROUGH THE SITE IS FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY AND IS NOT A SUBSTITUTE FOR THE PROFESSIONAL JUDGMENT OF A HEALTH CARE PROFESSIONAL IN DIAGNOSING AND TREATING PATIENTS. BIOMARIN DOES NOT GIVE MEDICAL ADVICE, NOR DOES IT PROVIDE MEDICAL OR DIAGNOSTIC SERVICES. YOUR RELIANCE UPON CONTENT OBTAINED BY YOU AT OR THROUGH THE SITE IS SOLELY AT YOUR OWN RISK.